(Q36618941)

15 August 2017

Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions (English)

1 reference

15 August 2017

0 references

Michihiro Nakayama

1

1 reference

15 August 2017

Atsutaka Okizaki

2

1 reference

15 August 2017

Shunta Ishitoya

3

1 reference

15 August 2017

Miki Sakaguchi

4

1 reference

15 August 2017

Junichi Sato

5

1 reference

15 August 2017

Tamio Aburano

6

1 reference

15 August 2017

language of work or name

1 reference

28 November 2012

1 reference

Annals of Nuclear Medicine

15 August 2017

1 reference

15 August 2017

27

1 reference

15 August 2017

2

1 reference

15 August 2017

163-169

1 reference

Creative Commons Attribution 2.0 Generic

15 August 2017

start time

28 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s12149-012-0669-1

0 references

cites work

Dual-time-point 18F-FDG PET/CT in patients with colorectal cancer: clinical value of early delayed scanning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Sarcoidosis and lymphoma: case series and literature review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Glucose metabolism correlated with cellular proliferation in diffuse large B-cell lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

The role of PET in lymphoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

An introduction to PET-CT imaging

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Positron emission tomography in the management of lung cancer

28 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Pattern and predictors of false positive lymph node involvement on positron emission tomography in patients with non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

18F-FDG PET in malignant lymphoma: significance of positive findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Advantage of delayed whole-body FDG-PET imaging for tumour detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-012-0669-1

Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

The usefulness of a repeat study for differentiating between bowel activity and local tumor recurrence on FDG PET scans

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

Unsuspected FDG-PET findings in the follow-up of patients with lymphoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575551

A PET study of 18FDG uptake in soft tissue masses

21 October 2018

1 reference

12 December 2020

Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck

1 reference

12 December 2020

Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas

1 reference

12 December 2020

The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?

1 reference

12 December 2020

201TL SPECT for evaluating head and neck cancer

1 reference

12 December 2020

10.1007/S12149-012-0669-1

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference